The Council for Innovation Promotion (C4IP) submitted its comments on the recent Listening Sessions hosted by the Federal Trade Commission (FTC) and Department of Justice (DOJ) on lowering drug prices in an August 15 letter addressed to Meredyth Andrus, an attorney in the Health Care Division, Bureau of Competition, at the FTC.

Full Article Available Here